FDA STATE_REFERRAL_LETTER - Medivera Compounding Pharmacy - June 05, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This STATE REFERRAL LETTER record concerns Medivera Compounding Pharmacy, with an inspection on June 5, 2017, issued by the Office of Regulatory Affairs, covering devices.

Company: Medivera Compounding Pharmacy
Inspection Date: June 5, 2017
Product Type: Devices
Office: Office of Regulatory Affairs
People: Art O. Czabaniuk (Program Division Director)
Tina M. Pawlowski (Compliance Officer)
Cheryl Wykoff Pezon
Joseph J. McCloskey

Open in Dashboard

ID · efb8e039-9c72-4b0e-b874-7adce8a0bc4e

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.